New York State Common Retirement Fund
NAMS icon

New York State Common Retirement Fund’s NewAmsterdam Pharma NAMS Stock Holding History

New York State Common Retirement Fund’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,800
Closed -$570K – 3280
2026
Q1 		$570K Sell
17,800
-8,880
-33% -$289K ﹤0.01% 1861
2025
Q4 		$936K Hold
26,680
– – ﹤0.01% 1736
2025
Q3 		$759K Buy
+26,680
New +$640K ﹤0.01% 1784

Other funds holding NAMS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

New York State Common Retirement Fund's NAMS Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of NewAmsterdam Pharma (NAMS) in Q2 2026, closing a stake of 17,800 shares — an estimated $570K sold.

New York State Common Retirement Fund first reported a position in NAMS in Q3 2025 and held it in 3 quarters. The position peaked at $936K in Q4 2025. 113 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • New York State Common Retirement Fund reported no remaining NewAmsterdam Pharma position as of Q2 2026 after selling out during the quarter.
  • New York State Common Retirement Fund sold 17,800 NewAmsterdam Pharma shares in Q2 2026, an estimated $570K.
  • New York State Common Retirement Fund first reported a position in NewAmsterdam Pharma in Q3 2025 and held it in 3 quarters.
  • New York State Common Retirement Fund's NewAmsterdam Pharma position peaked at $936K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.